Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

Platinum compounds have shown activity in a broad spectrum of human tumors in vitro and in vivo. The clinical utility of platinum agents in gynecologic and gastrointestinal cancers (particularly oxaliplatin in colorectal cancer) has been well documented and platinum agents continue to be evaluated in a variety of other cancers. Given preclinical evidence of synergy among some platinum compounds and new anticancer agents, clinical trials exploring platinum-based combination therapies may yield improved treatment for a variety of malignancies. Recent clinical data on new chemotherapeutic strategies for the treatment of lung, breast, and genitourinary cancers and myeloma will be presented in this review.

Original languageEnglish (US)
Pages (from-to)25-33
Number of pages9
JournalSeminars in Oncology
Volume31
Issue numberSUPPL. 14
DOIs
StatePublished - Dec 1 2004

All Science Journal Classification (ASJC) codes

  • Oncology

Fingerprint Dive into the research topics of 'Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma'. Together they form a unique fingerprint.

  • Cite this